SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 20, 2000
Medtronic, Inc.
(Exact name of Registrant as Specified in its Charter)
Minnesota
(State or Other Jurisdiction of Incorporation)
1-7707 41-0793183
(Commission File Number) (IRS Employer
Identification No.)
7000 Central Avenue N.E.
Minneapolis, Minnesota 55432-3576
(Address of Principal Executive Offices and Zip Code)
(763) 514-4000
(Registrant's telephone number, including area code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
<PAGE>
Item 5. Other Events
On November 20, 2000, the Registrant issued a press release relating to
second-quarter earnings. The full text of the press release is set forth in
Exhibit 99.1 which is attached hereto and incorporated in this Report as if
fully set forth herein.
On November 21, 2000, the Registrant issued a press release relating to
the Registrant's response to a ruling in the Johnson & Johnson/Cordis vs.
Medtronic AVE case. The full text of the press release is set forth in Exhibit
99.2 which is attached hereto and incorporated in this Report as if fully set
forth herein.
Item 7. Financial Statements and Exhibits
Exhibit 99.1 Press release dated November 20, 2000.
Exhibit 99.2 Press release dated November 21, 2000
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDTRONIC, INC.
By /s/ David J. Scott
Date: November 22, 2000 David J. Scott
Senior Vice President and
General Counsel
<PAGE>
EXHIBIT INDEX
Medtronic, Inc.
Form 8-K Current Report
Dated November 20, 2000
Exhibit Number Description
99.1 Press release dated November 20, 2000
99.2 Press release dated November 21, 2000
